SynAct Pharma AB
559058-4826ActiveClinical-stage biotech resolving inflammation via novel oral therapies.
Overview
- 5–9
- Employees
- 5–10M SEK
- Revenue
- 2016
- Founded
Key Decision Makers
Ann Kristin Led
Chief Financial Officer
Jeppe Øvlesen
Chief Executive Officer
Roy Fleischmann
Advisory Board Member
Ravi Rao
Advisory Board Member
+18 more contacts in Funnelfeedr
Description
SynAct Pharma is a clinical-stage biotechnology company dedicated to developing innovative medicines. Its core scientific approach centers on "Resolution Therapy," aiming to actively resolve ongoing inflammatory processes rather than merely inhibiting them. This strategy seeks to restore immune bala...
Tags
Keywords
Tech Stack
Company Information
- Industry
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Legal Form
- Aktiebolag
- VAT Number
- SE559058482601
Decision Makers
22 contacts in FunnelfeedrAnn Kristin Led
Chief Financial Officer
Jeppe Øvlesen
Chief Executive Officer
Roy Fleischmann
Advisory Board Member
Ravi Rao
Advisory Board Member
Mauro Perretti
Advisory Board Member
Björn Westberg
Chief Financial Officer
Malin Wikstrand
Interim Chief Financial Officer
Jeppe Ragnar Andersen
Board Member
Thomas Boesen, PhD.
Chief Operating Officer
Sten Sørensen
Board Member
Thomas Boesen
Chief Operating Officer
Thomas Jonassen, MD.
Chief Scientific Officer
James Knight
Advisory Board Member
Vibeke Strand
Advisory Board Member
Thomas Jonassen
Chief Scientific Officer
Sten Scheibye
Board Member
Mads Bjerregaard
Chief Business Officer
Kirsten Harting
Chief Medical Officer
Sten Sörensen
Board Member
Anders Kronborg
Chairman of the Board
Torbjørn Bjerke
Chief Executive Officer
Mauro Teixeira
Advisory Board Member
Similar Companies
20 similar companies in FunnelfeedrSynartro AB
1–4 employeesDeveloping sustained local injection treatments for osteoarthritis pain relief.
Pharmnovo Aktiebolag
1–4 employeesDeveloping non-addictive delta opioid receptor agonists for neuropathic pain.
Sangair AB
5–9 employeesDeveloping revolutionary blood treatment technology to combat severe sepsis infections.
Novakand Pharma AB
5–9 employeesDeveloping novel small-molecule drugs for inflammation and cancer.
PILA PHARMA AB
1–4 employeesClinical stage biotech developing an oral obesity and diabetes treatment.
Browse More
SynAct Pharma AB Questions
Want to see Funnelfeedr in action?
Book a free demo and discover how Funnelfeedr helps you find and convert your ideal customers.
Book a demo